{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:39:05Z","timestamp":1765485545801},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009885","name":"Regione Piemonte","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009885","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cyto.2011.08.020","type":"journal-article","created":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T10:46:56Z","timestamp":1315997216000},"page":"560-563","source":"Crossref","is-referenced-by-count":3,"title":["Proinflammatory cytokine gene polymorphisms and susceptibility to Paget\u2019s disease of bone: An association study"],"prefix":"10.1016","volume":"56","author":[{"given":"Salvatore","family":"Gallone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaola","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Criasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Pinessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Isaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocenzo","family":"Rainero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.08.020_b0005","unstructured":"Altman RD. Paget\u2019s disease of bone. In: Coe FL, Favus MJ, editors. Disorders of Bone and Mineral Metabolism. New York, NY, USA: Raven Press; 1991 pp. 1027\u20131064."},{"key":"10.1016\/j.cyto.2011.08.020_b0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S8756-3282(00)00345-8","article-title":"Osteoclast differentiation from circulating mononuclear precursors in Paget\u2019s disease is hypersensitive to 1,25-dihydroxivitamin D(3) and RANKL","volume":"27","author":"Neale","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.cyto.2011.08.020_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbmr.5650090111","article-title":"Interleukin 6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget\u2019s disease","volume":"9","author":"Hoyland","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cyto.2011.08.020_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/qjmed\/95.4.233","article-title":"The influence of serum cytokines and growth factors on osteoclast formation in Paget\u2019s disease","volume":"95","author":"Neale","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.cyto.2011.08.020_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI115584","article-title":"Interleukin 6 a potential autocrine\/paracrine factor in Paget\u2019s disease of bone","volume":"89","author":"Roodman","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2011.08.020_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.0105-2896.2005.00323.x","article-title":"The role of immune cells and inflammatory cytokines in Paget\u2019s disease and multiple myeloma","volume":"208","author":"Ehrlich","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2011.08.020_b0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bone.2004.11.004","article-title":"Interleukin-6 and osteoprotegerin systems in Paget\u2019s disease of bone: relationship to risedronate treatment","volume":"36","author":"Mossetti","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.cyto.2011.08.020_b0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1600-0765.2000.035003172.x","article-title":"Effect of the interleukin-1 genotype on monocyte IL-1beta expression in subjects with adult periodontitis","volume":"35","author":"Mark","year":"2000","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.cyto.2011.08.020_b0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00024382-200309000-00004","article-title":"Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses","volume":"20","author":"Rivera-Chavez","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.cyto.2011.08.020_b0050","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2011.08.020_b0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s100380170077","article-title":"A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density","volume":"46","author":"Ota","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cyto.2011.08.020_b0060","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1359\/JBMR.040707","article-title":"Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women","volume":"19","author":"Moffett","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cyto.2011.08.020_b0065","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2004-2235","article-title":"tumour necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women","volume":"90","author":"Moffett","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2011.08.020_b0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bone.2005.09.010","article-title":"511 C\/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone","volume":"38","author":"Corral-Gudino","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.cyto.2011.08.020_b0075","unstructured":"Resnick D, Niwayama G. Paget\u2019s disease. In: Resnick D, Niwayama G, editors. Diagnosis of Bone and Joint Disorders. Philadelphia: W.B. Saunders; 1981 pp. 1721\u20131754."},{"key":"10.1016\/j.cyto.2011.08.020_b0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N","article-title":"Association of early onset Alzheimer\u2019s disease with an interleukin-1A gene polymorphism","volume":"47","author":"Grimaldi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cyto.2011.08.020_b0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(97)00161-6","article-title":"Polymorphisms in IL-1\u03b2 and IL-1 receptor antagonist genes are associated with myasthenia gravis","volume":"81","author":"Huang","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.08.020_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-5728(99)00140-X","article-title":"Polymorphism at -174 and in the 3\u2019 flanking region of interleukin-6 (Il-6) gene in patients with myasthenia gravis","volume":"101","author":"Huang","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.08.020_b0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cyto.2011.08.020_b0100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.57.7.1153","article-title":"Genetic association studies: genes in search of diseases","volume":"57","author":"Bird","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2011.08.020_b0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1744-313X.2005.00537.x","article-title":"Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men","volume":"32","author":"Chiappelli","year":"2005","journal-title":"Int Immunogenet"},{"key":"10.1016\/j.cyto.2011.08.020_b0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2370.2003.00361.x","article-title":"Genotyping for cytokine polymorphisms: allele frequencies in the Italian population","volume":"30","author":"Uboldi de Capei","year":"2003","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.cyto.2011.08.020_b0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2010.07.008","article-title":"Paget\u2019s disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8 and tumour necrosis factor alpha genes","volume":"52","author":"Corral-Gudino","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.08.020_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2006.07.001","article-title":"Detection of hearing impairment and handicap in Paget\u2019s disease of bone using a simple scoring system: a case control study","volume":"40","author":"Young","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.cyto.2011.08.020_b0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00129492-200205000-00015","article-title":"Clinical implications of inflammatory cytokines in the cochlea: a technical note","volume":"23","author":"Adams","year":"2002","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.cyto.2011.08.020_b0130","series-title":"The parathyroid glands and metabolic bone disease","author":"Albright","year":"1948"},{"key":"10.1016\/j.cyto.2011.08.020_b0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(08)61035-1","article-title":"Pathogenesis and management of Paget\u2019s disease of bone","volume":"372","author":"Ralston","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2011.08.020_b0140","doi-asserted-by":"crossref","first-page":"P38","DOI":"10.1359\/jbmr.06s207","article-title":"Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget\u2019s disease of bone","volume":"21","author":"Morissette","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cyto.2011.08.020_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000464","article-title":"The molecular pathogenesis of Paget disease of bone","volume":"9","author":"Layfield","year":"2007","journal-title":"Expert Rev Mol Med"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2011.08.020_b0150","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2091-8-S1-S5","article-title":"Ubiquitin-mediated signalling and Paget\u2019s disease of bone","volume":"8","author":"Layfield","year":"2007","journal-title":"BMC Biochem"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611006831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611006831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:20:32Z","timestamp":1588810832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611006831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1043466611006831"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.08.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}